Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.18 USD | -0.62% | -1.55% | -35.76% |
May. 06 | Genenta Science S.p.A. Announces New Board Appointments | CI |
Apr. 08 | Genenta Science S.P.A. Announces Resignation of Board Members | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 53.3M 57.87M |
---|---|---|---|---|---|
Net income 2024 * | -18M -19.55M | Net income 2025 * | -24M -26.06M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.48
x | P/E ratio 2025 * |
-3.29
x | Employees | 14 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.08% |
1 day | -0.63% | ||
1 week | -1.55% | ||
Current month | +3.25% | ||
1 month | -7.35% | ||
3 months | -28.05% | ||
6 months | -37.65% | ||
Current year | -35.76% |
Managers | Title | Age | Since |
---|---|---|---|
Bernhard Gentner
FOU | Founder | - | 14-07-23 |
Luigi Naldini
FOU | Founder | - | 14-07-23 |
Chief Executive Officer | 50 | 14-07-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Marucci
BRD | Director/Board Member | 62 | 21-05-19 |
Roger Abravanel
BRD | Director/Board Member | 77 | 21-05-19 |
Chief Executive Officer | 50 | 14-07-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 3.18 | -0.63% | 1,341 |
24-05-15 | 3.2 | -0.62% | 3,556 |
24-05-14 | 3.22 | -8.15% | 2,070 |
24-05-13 | 3.506 | +13.09% | 1,082 |
24-05-10 | 3.1 | -4.02% | 17,777 |
Delayed Quote Nasdaq, May 16, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.76% | 58.29M | |
+33.37% | 49.46B | |
+1.55% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
-21.00% | 18.64B | |
+7.36% | 13.16B | |
+28.30% | 12.55B | |
+23.80% | 12.1B |
- Stock Market
- Equities
- GNTA Stock